These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 7904421

  • 1. Interactions of cAMP-mediated vasodilators with angiotensin II in rat kidney during hypertension.
    Chatziantoniou C, Ruan X, Arendshorst WJ.
    Am J Physiol; 1993 Dec; 265(6 Pt 2):F845-52. PubMed ID: 7904421
    [Abstract] [Full Text] [Related]

  • 2. Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension.
    Chatziantoniou C, Ruan X, Arendshorst WJ.
    Proc Natl Acad Sci U S A; 1995 Mar 28; 92(7):2924-8. PubMed ID: 7708750
    [Abstract] [Full Text] [Related]

  • 3. Impaired ability of prostaglandins to buffer renal vasoconstriction in genetically hypertensive rats.
    Chatziantoniou C, Arendshorst WJ.
    Am J Physiol; 1992 Oct 28; 263(4 Pt 2):F573-80. PubMed ID: 1329556
    [Abstract] [Full Text] [Related]

  • 4. Role of protein kinase C in angiotensin II-induced renal vasoconstriction in genetically hypertensive rats.
    Ruan X, Arendshorst WJ.
    Am J Physiol; 1996 Jun 28; 270(6 Pt 2):F945-52. PubMed ID: 8764313
    [Abstract] [Full Text] [Related]

  • 5. Vascular interactions of prostaglandins with thromboxane in kidneys of rats developing hypertension.
    Chatziantoniou C, Arendshorst WJ.
    Am J Physiol; 1993 Aug 28; 265(2 Pt 2):F250-6. PubMed ID: 8396345
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin II-induced changes in G-protein expression and resistance of renal microvessels in young genetically hypertensive rats.
    Vyas SJ, Blaschak CM, Chinoy MR, Jackson EK.
    Mol Cell Biochem; 2000 Sep 28; 212(1-2):121-9. PubMed ID: 11108143
    [Abstract] [Full Text] [Related]

  • 7. Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats.
    Chatziantoniou C, Daniels FH, Arendshorst WJ.
    Am J Physiol; 1990 Aug 28; 259(2 Pt 2):F372-82. PubMed ID: 2386211
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin and thromboxane in genetically hypertensive rats: renal blood flow and receptor studies.
    Chatziantoniou C, Arendshorst WJ.
    Am J Physiol; 1991 Aug 28; 261(2 Pt 2):F238-47. PubMed ID: 1831598
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II-induced renal vasoconstriction in genetic hypertension.
    Jackson EK, Herzer WA, Vyas SJ, Kost CK.
    J Pharmacol Exp Ther; 1999 Oct 28; 291(1):329-34. PubMed ID: 10490921
    [Abstract] [Full Text] [Related]

  • 10. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors.
    Feng JJ, Arendshorst WJ.
    Am J Physiol; 1996 Aug 28; 271(2 Pt 2):F304-13. PubMed ID: 8770161
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin II: enhanced renal responsiveness in young genetically hypertensive rats.
    Vyas SJ, Jackson EK.
    J Pharmacol Exp Ther; 1995 May 28; 273(2):768-77. PubMed ID: 7752079
    [Abstract] [Full Text] [Related]

  • 12. The inhibitory effect of angiotensin II on stimulus-induced release of cAMP is augmented in the genetically hypertensive rat kidney.
    Vyas SJ, Mi Z, Jackson EK.
    J Pharmacol Exp Ther; 1996 Oct 28; 279(1):114-9. PubMed ID: 8858983
    [Abstract] [Full Text] [Related]

  • 13. Renal dopamine receptors and pre- and post-cAMP-mediated Na+ transport defect in spontaneously hypertensive rats.
    Horiuchi A, Albrecht FE, Eisner GM, Jose PA, Felder RA.
    Am J Physiol; 1992 Dec 28; 263(6 Pt 2):F1105-11. PubMed ID: 1362327
    [Abstract] [Full Text] [Related]

  • 14. Effects of angiotensin 1-7 on the actions of angiotensin II in the renal and mesenteric vasculature of hypertensive and streptozotocin-induced diabetic rats.
    Dharmani M, Mustafa MR, Achike FI, Sim MK.
    Eur J Pharmacol; 2007 Apr 30; 561(1-3):144-50. PubMed ID: 17320855
    [Abstract] [Full Text] [Related]

  • 15. Role of endothelin-1 and thromboxane A2 in renal vasoconstriction induced by angiotensin II in diabetes and hypertension.
    Cediel E, Vázquez-Cruz B, Navarro-Cid J, de las Heras N, Sanz-Rosa D, Cachofeiro V, Lahera V.
    Kidney Int Suppl; 2002 Dec 30; (82):S2-7. PubMed ID: 12410847
    [Abstract] [Full Text] [Related]

  • 16. Exaggerated tubuloglomerular feedback activity in genetic hypertension is mediated by ANG II and AT1 receptors.
    Brännström K, Morsing P, Arendshorst WJ.
    Am J Physiol; 1996 May 30; 270(5 Pt 2):F749-55. PubMed ID: 8928835
    [Abstract] [Full Text] [Related]

  • 17. Low-dose angiotensin II reduces urinary cyclic AMP excretion in spontaneously hypertensive, but not normotensive, rats: independence from hypertension and renal hemodynamic effects of angiotensin.
    Jackson EK, Herzer WA, Mi Z, Vyas SJ, Kost CK.
    J Pharmacol Exp Ther; 1999 Oct 30; 291(1):115-23. PubMed ID: 10490894
    [Abstract] [Full Text] [Related]

  • 18. AT-1 receptor antagonism modifies the mediation of endothelin-1, thromboxane A2, and catecholamines in the renal constrictor response to angiotensin II.
    Cediel E, de Las Heras N, Sanz-Rosa D, Velasco O, Cachofeiro V, Lahera V.
    Kidney Int Suppl; 2005 Jan 30; (93):S3-9. PubMed ID: 15613065
    [Abstract] [Full Text] [Related]

  • 19. Role of angiotensin in the renal vasoconstriction observed during the development of genetic hypertension.
    Arendshorst WJ, Chatziantoniou C, Daniels FH.
    Kidney Int Suppl; 1990 Nov 30; 30():S92-6. PubMed ID: 2259085
    [Abstract] [Full Text] [Related]

  • 20. Enhanced renal angiotensin II subtype 1 receptor responses in the spontaneously hypertensive rat.
    Kost CK, Jackson EK.
    Hypertension; 1993 Apr 30; 21(4):420-31. PubMed ID: 8458644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.